The symptoms are less severe in patients with CD3G mutations, and only two (20%) of all 10 published cases received HSCT due to refractory IBD, AIHA, and granulomatous lymphocytic interstitial lung disease or severe life-threatening infections. The gene discussed is CD3G; the disease is infection.